With the beta launch of Catalyst, Molecule invites you to embark on an exciting journey with Catalyst Quests—a gamified adventure designed to onboard users into the DeSci movement. 

Catalyst Quests empowers our community to interact with early-stage research projects listed on Catalyst by completing various activities, sharing feedback, and growing the DeSci ecosystem. In return, participants will earn experience points (XP), which are used to measure engagement and identify the leading patrons of science. 

Put simply, participate in quests, earn XP, and climb the DeSci leaderboard. 

‍

How Catalyst Quests Works

Hosted on Rep3, Catalyst Quests has two types of challenges: ‍

Research Project Quests:

Each time a project is listed on Catalyst, a new quest is launched, creating more XP-earning opportunities. The quest tasks include: 

• Project Due Diligence: Join research discussions on X and attend researcher AMAs.
• Sharing Feedback: Provide feedback on specific project information and future Catalyst features. 
• Funding Science: Back a project that aligns with a funder's interests.‍

‍

‍Side Quests: 

Engage in fun and interactive activities to earn XP, including:

• Patron of Science Quiz: Take a BuzzFeed-style quiz to discover your Patron of Science.
• Creating Content: Make and share content related to Catalyst to spread the word.
• Following Our Socials: Follow our social media accounts to stay updated.
• Creating Memes: Share your creativity by making and posting memes about Catalyst.

— and more in the future! 

‍

Streak Incentive

Users who participate in consecutive Research Project quests will receive a streak boost. Here is how it works: 

• Base Points: Complete tasks in a quest to earn XP. For example, a single Research Project Quest is worth 100 XP.
• Streak Boost: Points increase with each consecutive week of Research Project Quest completion. The more consistent your participation, the more XP you earn:
  • Project 1 Quest: 100 XP
  • Project 2 Quest: 100 XP + 50 XP Boost = 150 XP 
  • Project 3 Quest: 100 XP + 50 XP Boost = 150 XP 

‍

Join Catalyst Quests

Joining Catalyst Quests is a chance to make your mark in the DeSci movement. As you earn XP and rise through the DeSci leaderboard, you'll proudly show your early support for innovative research and the broader DeSci space. 

Exclusive Insider Access Boost: As a thank you for your early support, Catalyst Insider Access List participants will receive additional boosts on their earned XP. This exclusive boost is our way of saying thank you for being a DeSci pioneer and helping us shape the future of scientific funding. 

Ready to try Catalyst and earn XP? Start your first quest now and start racking up your XP. 

For more information about Catalyst, check out the docs and shape the future of decentralized science funding.

‍

About Molecule

Molecule is dedicated to advancing scientific research through democratized funding and the tokenization of intellectual property (IP). By transforming IP into liquid, onchain assets, Molecule aligns the incentives of researchers and funders, fostering a more collaborative and efficient research ecosystem. 

‍

Early-stage biomedical research funding is plagued by a mismatch between funded and impactful research. This disconnect results in detrimental diseases being underfunded despite their impact on public health. For instance, conditions like longevity, hair loss, women’s health, cryonics, and brain aging often receive disproportionately less funding compared to their prevalence and burden on society.

Public funds play a substantial role in financing research. In Europe, approximately 0.74% of GDP is allocated to research and development (R&D), representing a significant public investment. In the United States, the investment is even higher, with R&D expenditures accounting for around 3.4% of GDP. Despite this forced, substantial investment by taxpayers, the public has almost no influence over how these funds are allocated.

Enter Catalyst. By utilizing blockchains, Catalyst democratizes research funding, allowing individuals to directly support projects that resonate with them. This decentralized model aims to rectify the inefficiencies of the current research funding apparatus, ensuring that funding better aligns with societal needs. 

Catalyst empowers individuals to use their cryptocurrency to make impactful decisions, fostering a more transparent and impactful research funding protocol.

‍

Introducing Catalyst: Aligning Incentives Through Onchain Intellectual Property

Molecule is thrilled to unveil Catalyst, the decentralized science (DeSci) funding machine. Catalyst aims to fuel scientific advancements by enabling democratized research funding through tokenizing intellectual property (IP). 

Catalyst forms communities around the drug development process and empowers individuals to support meaningful scientific research. In exchange for funding the research, funders receive tokens with rights to the research IP. This creates aligned incentives for researchers and funders to collaborate to bring more breakthroughs to those in need. 

‍

Benefits of Catalyst

For Funders:

• Purchase Tokens to Fund Research: Funders can contribute directly to advancing scientific research ideas. 
• Take Part in Research and Licensing Decisions: In exchange for funding contributions, funders receive IP tokens, which gives them the right to participate in certain research and IP licensing decisions. 
• Trade Tokens to Match Evolving Interests: Funders can trade their IP tokens on decentralized exchanges, giving them the flexibility to match their evolving interests.

‍

For Researchers: 

• Access to a Network of Global Funders: Catalyst opens up new avenues for funding beyond traditional sources.
• Build Community Around Your Research: IP Tokens are tools for building engaged communities around research, so researchers can connect with passionate supporters and collaborators. 
• Focus on Science: Researchers can concentrate on pursuing and advancing scientific work.

‍

How Catalyst Works

Catalyst works by turning scientific ideas into digital tokens (IP Tokens). IP Tokens allow researchers to grant funders rights in exchange for backing their project. These rights create a shared incentive for researchers and funders to collaborate together to make the research valuable. 

But what rights do these IP Token holders have? The right to govern and access IP is limited by the IP-NFT holder. The governance decisions could include: 

• Voting on proposed IP licenses
• Deciding on the distribution of proceeds earned from the IP-NFT and its IP
• Signaling support for experimental and clinical trial designs 

Using IP Tokens and shared governance rights, Catalyst aligns the interests of researchers and funders, making it easier for them to collaborate around budding research ideas. 

‍

The Foundational Pieces of Catalyst

Catalyst brings together key infrastructure to tackle the scalability and incentive challenges traditional research funding models face. These components include:

Democratized Funding: Catalyst creates access to funding opportunities without the need for traditional intermediaries, enabling anyone to participate in funding research projects.

IP Tokenization: Catalyst converts research funding into IP Tokens. IP Tokens grant the token holder rights to exclusive data, voting on project execution details, licensing the intellectual property to patients and pharmaceutical organizations, and determining how proceeds earned from licensing are distributed to token holders. 

Bonding Curves: Bonding curves distribute IP tokens, rewarding early funders with a larger share of tokens. Funders can contribute or withdraw funds until a project meets its funding goal, making funding science unruggable. 

‍Liquidity Provision: A portion of IPTs is used to set up a liquidity pool on a decentralized exchange, allowing funders to swap their tokens and enhancing flexibility.

‍

A New Era of Incentive-Driven Research Funding

By leveraging blockchain technology and tokenized intellectual property, Catalyst creates a dynamic, democratized funding marketplace that brings together researchers and funders, accelerating scientific progress. For more information, check out our documentation. 

‍

Jumpstart the DeSci Machine; Get Insider Access

Molecule is gearing up for Catalyst’s beta launch. We invite you to be among the first to experience funding groundbreaking research projects and join the DeSci movement. 

To celebrate the upcoming launch, we encourage you to sign up for Catalyst Insider Access. By joining now, you'll be the first to receive exciting updates and exclusive information on what's coming next. Trust us—you won't want to miss out on what's coming.

Be the first to know, and get ready to jumpstart the future of decentralized science funding.

‍

About Molecule

Molecule is dedicated to advancing scientific research through democratized funding and the tokenization of intellectual property (IP). By transforming IP into liquid, onchain assets, Molecule aligns the incentives of researchers and funders, fostering a more collaborative and efficient research ecosystem.

Molecule, a leader in decentralized science (DeSci) and a pioneer in tokenized intellectual property (IP), is thrilled to announce its strategic partnership with CryoDAO, a decentralized collective dedicated to funding high-impact research to advance cryopreservation techniques. 

Working on the bleeding edge of scientific innovation, CryoDAO’s mandate is to make death optional. We will be working together to further their mission, bringing cryopreservation research projects to the DeSci community utilizing Molecule IP tokens: IP-NFTs and IPTs.  

‍

Powered by Molecule IP Tokens 

Molecule IP tokens transform the management of scientific IP through tokenization:

• Intellectual Property NFTs (IP-NFTs): IP-NFTs are non-fungible tokens that register scientific IP onchain. IP-NFTs provide a secure, immutable record of scientific IP ownership and rights, enabling easy IP transfer, verification, and management.
• Intellectual Property Tokens (IPTs): IPTs are fungible tokens that distribute the IP rights associated with a particular IP-NFT, decentralizing its scientific process by enabling globally distributed governance of it and transforming the way scientists engage with their online communities.  

Molecule IP-NFTs and IPTs empower CryoDAO to accelerate the pace of cryopreservation research and funding by bringing scientific IP onchain.  

‍

Combining Biotech Dealflow Expertise

Working closely with the CryoDAO scientific research dealflow team, Molecule’s biotech team will aid in experimental planning, IP strategy, and negotiation, leveraging an existing partnership with Nucleate. 

You can learn more about Molecule’s partnership with Nucleate to source cutting-edge scientific research for IP tokenization from all around the world here. 

Together, CryoDAO and Molecule will build a pipeline of groundbreaking cryopreservation research projects and tokenize them.  

‍

Growing Onchain IP Through Cryopreservation

This collaboration marks an important step towards a more vibrant and innovative DeSci ecosystem, leveraging the strengths of both organizations to make a meaningful impact. To stay up to date on the partnership, follow Molecule on X or sign up for our newsletter. 

"We are thrilled to enter into this cool partnership with CryoDAO, which accelerates our vision of tokenizing scientific IP, enabling new sources of capital to fund valuable, underfunded research areas like cryonics. We believe that DeSci has the opportunity to make crypto a force for enabling researchers to work on humanity’s biggest problems and for communities to bring discoveries to life that would never have existed otherwise. We are excited to charge the chilling growth of the CryoDAO community to make cryonics a reality and make taxes the only guarantee in life." Benji Leibowitz, COO at Molecule

“Together with Molecule, CryoDAO will push the boundaries of decentralized science, tokenizing the most important research in the world—research that will save our very lives. By calling on a global community to advance this science, we have an opportunity to change the course of human history forever. This partnership is an important first step.”  Kai Micah Mills, co-founder of CryoDAO.

‍

About Molecule

Molecule is dedicated to advancing scientific research through permissionless funding and the tokenization of intellectual property (IP). By transforming scientific IP into a liquid onchain asset, Molecule aligns the incentives of researchers and funders, fostering a more collaborative and efficient research ecosystem. 

‍

About CryoDAO

CryoDAO envisions a world where organs and tissues preserved in vast biobanks are available to patients on demand, where journeys to distant stars become journeys in slumber, and where even life can be frozen in time. CryoDAO funds research projects that have a high potential to increase the quality and capabilities of cryopreservation.